NTLA 5001, a T Cell Product Candidate with CRISPR Based Targeted Insertion of a High Avidity, Natural, WT1 Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
